COR vs ICE · P/E 21, rev $321.33B vs P/E 37, rev $12.64B
Cencora Inc. (COR) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
COR currently screens at market cap $53.91B and trailing P/E 21.2. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the COR and ICE stock pages for the full models.
Not investment advice.